Thoracic stent graft versus surgery for thoracic aneurysm.
2016; National Institutes of Health; Issue: 6 Linguagem: Inglês
10.1002/14651858.cd006796.pub4
AutoresIosief Abraha, Carlo Romagnoli, Alessandro Montedori, Roberto Cirocchi,
Tópico(s)Infectious Aortic and Vascular Conditions
ResumoThoracic aortic aneurysm (TAA) is an uncommon disease with an incidence of 10.4 per 100,000 inhabitants. It occurs mainly in older individuals and is evenly distributed among both sexes. There are no signs or symptoms indicative of the presence of the disease. Progressive but unpredictable enlargement of the dilated aorta is the natural course of the disease and can lead to rupture. Open chest surgical repair using prosthetic graft interposition has been a conventional treatment for TAAs. Despite improvements in surgical procedures perioperative complications remain significant. The alternative option of thoracic endovascular aneurysm repair (TEVAR) is considered a less invasive and potentially safer technique, with lower morbidity and mortality compared with conventional treatment. Evidence is needed to support the use of TEVAR for these patients, rather than open surgery. This is an update of the review first published in 2009.
Referência(s)